Abstract-Heterocyclic derivatives of polycyclic aromatic hydrocarbons (PAHs) are often significant components of environmental contaminant mixtures; however, their contribution to the toxicity of these mixtures is not well characterized. These heterocycles commonly co-occur in PAH mixtures, which contain agonists for the aryl hydrocarbon receptor (AHR). Our goal for these studies was to explore the effects of two PAH heterocycles, carbazole (CB) and dibenzothiophene (DBT), alone and in combination with a PAH-type agonist for the AHR (␤-naphthoflavone [BNF]) on AHR-mediated cytochrome P4501A (CYP1A) activity and on fish embryotoxicity. Embryos of Fundulus heteroclitus were exposed to CB or DBT, with and without coexposure to BNF. Carbazole alone slightly induced, whereas DBT alone slightly reduced, in ovo CYP1A-mediated ethoxyresorufin-O-deethylase (EROD) activity compared to control values. However, exposure to CB or DBT reduced in ovo EROD activity in embryos coexposed to BNF. Carbazole and DBT were characterized in vitro as noncompetitive CYP1A inhibitors. Carbazole and DBT enhanced the embryotoxicity of BNF, although neither compound was embryotoxic by itself. The co-occurrence of CB and DBT with PAH-type AHR inducers in contaminated ecosystems may increase the toxicity of PAH-type AHR agonists in these settings and may need to be considered when estimating the embryotoxicity of PAH mixtures.
INTRODUCTION
Polycyclic aromatic hydrocarbon (PAH) heterocycles are PAHs in which one or more of the carbons within the aromatic structure is substituted by a nitrogen, sulfur, or oxygen atom [1] . These compounds co-occur in PAH mixtures and can constitute 1 to 10% of the total PAH concentration in contaminated sediments, and tend to make up higher percentages in mixtures derived from creosote or tar [2] . Heterocycles are generally more water soluble and tend to have lower log octanol-water partition coefficients (log K OW s) than unsubstituted PAHs, and therefore have relatively less tendency to sorb to soil particles, and greater tendency to partition to the water column over and to groundwater under contaminated sediments [1, 3] . One study of groundwater near gasification plants in Denmark detected a total heterocycle concentration of more than 500 g/L, compared to total PAH concentrations at the same site of 61 g/ L [3] . Similar levels of heterocycle water contamination have been reported in areas surrounding coal and oil gasification plants and near a wood-treatment plant in the United States [4, 5] . Sediment from a creosote-contaminated site on the Elizabeth River, Virginia, USA, was found to have total heterocycles at levels greater than 100 mg/kg (R. Hale, Virginia Institute of Marine Science, Gloucester Point, VA, USA, unpublished data).
The toxicities of heterocycles are poorly understood. Acute toxicities of aqueous exposures to heterocycles were found to be greater than their unsubstituted hydrocarbon counterparts in Daphnia magna [6] . However, in studies involving terrestrial invertebrates, the toxicities of heterocycles including dibenzothiophene (DBT) and carbazole (CB) were not found to be significantly different than their unsubstituted hydrocarbon counterparts, and dose-response relationships for these compounds were consistent with a narcotic mechanism of toxicity [7] [8] [9] . Some heterocycles and their derivatives have been found to be mutagenic; however, CB and DBT (the heterocycles used in this study; Fig. 1 ) have not [10] [11] [12] .
The aryl hydrocarbon receptor (AHR) is a ligand-mediated receptor whose activation initiates transcription of numerous genes including the mono-oxygenase cytochrome P4501A (CYP1A) [13] . Although heterocycles occur in mixtures that contain established AHR agonists, little is known about interactions between heterocycles and the AHR pathway or CYP1A activity. Dibenzothiophene does not induce AHR-regulated mono-oxygenase activity in rats, but it is a good substrate for mono-oxygenases [14] . Additionally, little is known about the effects of coexposure of heterocycles with AHR agonists. In one study, DNA adduct formation detected by 32 Ppostlabeling in mice treated with the environmentally occurring N-heterocycle, 5,9-dimethyldibenzo[c,g]carbazole, was reduced by cotreatment with AHR agonists, ␤-naphthoflavone (BNF) and 2,3,7,8-tetracholorodibenzo-p-dioxin (TCDD; [15] ). However, Dutson et al. [12] found that metabolic activation by S9 supernatant increased the mutagenicity, as determined by the Ames Salmonella/microsome assay, of benzo[a]carbazole but not that of CB.
Effects of CB and DBT on CYP1A activity and deformities Environ. Toxicol. Chem. 24, 2005 2527 Environmental PAH mixtures often induce expression and activity of CYP1A in fish, presumably because of the presence of AHR agonists in these mixtures [16] [17] [18] [19] . In these studies, we examined the effects of the environmentally occurring heterocycles, CB and DBT, on CYP1A activity in vitro, by using microsomes from channel catfish (Ictalurus punctatus), and in ovo, in the killifish Fundulus heteroclitus. Carbazole and DBT both decreased BNF-induced CYP1A activity as measured by in vitro and in ovo ethoxyresorufin-O-deethylase (EROD) activity. Kinetic analysis indicated that the compounds are noncompetitive EROD inhibitors.
Environmental PAH mixtures and some individual PAHs induce embryonic deformities in fish including pericardial edema, heart elongation, tail malformations, and hemorrhaging that resemble the ''blue sac disease'' induced by another AHR agonist, TCDD [20] [21] [22] [23] . We recently reported synergistic embryotoxicity between PAH-type AHR agonists and CYP1A inhibitors of varying structures and mechanisms of inhibition [21, 24] , including another noncompetitive CYP1A inhibitor, fluoranthene, whose kinetics resemble those of CB and DBT [25, 26] . We hypothesized that CB and DBT, like previously tested CYP1A inhibitors, would synergize with a PAH-type AHR agonist in their effects on embryonic deformities. To test this hypothesis, embryos were exposed to CB and DBT alone and in combination with BNF, a PAH-type AHR agonist that has been shown to induce blue sac-like deformities in killifish embryos [24] . In support of our hypothesis, DBT was synergistic with BNF. Carbazole, although not statistically synergistic, showed the same general trend for increasing embryonic deformities elicited by BNF.
MATERIALS AND METHODS

Reagents
Dimethylsulfoxide (DMSO), sucrose, Tris-HCl, Tris-base, and KCl were purchased from Mallinckrodt Baker (Phillipsburg, NJ, USA). N-[2hydroxyethyl] piperazine NЈ-[2-ethanesulfonic acid] (HEPES) and glycerol were purchased from EMD Chemicals (Gibbstown, NJ, USA). All other reagents were purchased from Sigma Aldrich (St. Louis, MO, USA).
Channel catfish microsome preparation
Channel catfish were used to prepare large quantities of CYP1A-induced microsomes for in vitro analysis of CB and DBT effects on CYP1A activity. Six channel catfish ranging in weight from 108 to 360 g were injected intraperitoneally with either corn oil (vehicle control) or BNF (a model AHR agonist) at 10 mg/kg. Injection volume was 2.5 l/g fish. At 48 h after injection, livers were removed, rinsed in cold 0.15 M KCl, and homogenized in cold buffer (0.25 M sucrose, 0.1 M Tris-HCl, 1 mM ethylenediaminetetraacetic acid [EDTA], pH 7.4). Homogenates were centrifuged at 10,000 g for 20 min, and the resulting supernatants were centrifuged at 100,000 g for 1 h. Pellets were washed with 0.15 M Tris-base (pH 8.0) and resuspended in 500 l of microsome resuspension buffer (0.25 M sucrose, 0.1 M Tris-HCl, 1 mM EDTA, 20% glycerol, pH 7.4). Aliquots were flash frozen in liquid nitrogen and stored at Ϫ80ЊC. Microsome protein concentrations were determined by the Bio-Rad Protein Assay kit (Hercules, CA, USA). Ethoxyresorufin-O-deethylase activities of control and BNF-treated channel catfish microsomes were analyzed (method is described below), and induced microsomes were found to have roughly sevenfold higher EROD activity than controls (348.23 Ϯ 147.48 and 48.55 Ϯ 22.44 pmol/min/mg, respectively). Only microsomes from one of the BNF-induced catfish were used in further experiments (EROD activity 456.63 pmol/ min/mg).
In vitro EROD assays
Ethoxyresorufin-O-deethylase activities in channel catfish microsomes were determined as described by Willett et al. 
Embryo experiments-Experimental design
Three coexposure experiments were conducted with killifish embryos. In the first, embryos were exposed to a range of CB or DBT concentrations (10-500 g/L; all exposure concentrations are nominal) with or without BNF at 1 g/L (a BNF concentration previously shown to induce in ovo EROD without causing deformities). In the second and third experiments, embryos were exposed to a range of BNF concentrations (1-100 g/L) with or without CB or DBT at 500 g/L. Eight to 10 embryos were dosed per treatment group, and each embryo was observed for in ovo EROD activity and deformities.
Embryo exposures and in ovo EROD
An in ovo EROD method modified slightly from the method by Nacci et al. [28, 29] was used to measure the in ovo CYP1A activity of embryos. Briefly, killifish embryos were obtained from in vitro fertilization of pooled oocytes stripped from 9 to 12 females with pooled milt from 4 or 5 males. Several hours after fertilization, embryos with dividing cells were selected and placed individually in 20-ml scintillation vials with 10 ml of artificial seawater (Instant Ocean, Mentor, OH, USA; 20‰) containing ethoxyresorufin at 21 g/L with or without inducer (BNF), inhibitor (CB or DBT), or both at 1 g/L. An embryo with a slight pericardial edema and heart elongation (deformity score of 2 out of 5). The tail is not visible in this photo because it is curved behind the embryo. (C) An embryo with major pericardial edema, heart elongation, and tail deformity (deformity score of 5 out of 5). H ϭ heart; T ϭ tail; PC ϭ pericardial sac. Embryos measure 1.8 mm in diameter.
Dimethylsulfoxide was used as a solvent and solvent concentrations were less than 0.1% (v/v) for all treatments. Embryos were in dosing solution for 7 d at 25ЊC, during which resorufin, the fluorescent product of CYP1A metabolism of ethoxyresorufin, accumulated in the embryos' bilobed urinary bladders. On day 7 of development, embryos were placed in clean artificial seawater and embryo bladders were visualized by fluorescent microscopy (ϫ50 magnification with a rhodamine red filter set; Zeiss Axioskop, Thornwood, NY, USA). The EROD activity was measured as intensity of the bladder fluorescence and was quantified digitally by IP laboratory software (Scanalytics, Fairfax, VA, USA). In ovo EROD values were expressed as a percent of control intensity.
Deformity assessment
Embryos were scored blind for heart elongation (tube heart), pericardial edema, tail shortening, and hemorrhaging on day 10 of development (hatch typically occurs on day 14). Photos of various deformities observed in these experiments can be found in Figure 2 . Heart deformities were found to be the most sensitive endpoint scored, so this endpoint was used for further analysis. Heart elongation severity was ranked between 0 and 5 by using the following criteria for the score: 0 ϭ no elongation, 1 ϭ very mild elongation, normal blood flow; 2 ϭ mild elongation with heart chambers slightly skewed from medial-lateral orientation; 3 ϭ moderate elongation, heart chambers skewed from medial-lateral orientation and some restriction of blood flow; 4 ϭ severe elongation of heart vessels, heart chambers on anterior-posterior orientation, blood flow almost completely restricted, but still passage of blood cells through the heart; 5 ϭ severe elongation of heart vessels, heart chambers on anterior-posterior orientation, blood flow completely blocked. A deformity index for each treatment was calculated as sum of scores for individuals in that treatment group divided by the maximum score possible (the number of individuals multiplied by 5). This quotient was then multiplied by 100.
Data analysis and statistics
Inhibitor concentrations to achieve 50% inhibition (IC50) values were determined by using probit analysis (Tox Stat Software Ver 3.5, West Cheyenne, WY, USA). Kinetic data were plotted as double reciprocal plots and the Michaelis constant (K m ) and the maximum velocities (V max ) were calculated from the x and y intercepts, respectively. Inhibitory constant (K i ) values were calculated by using an equation for noncompetitive inhibition
Other statistical analyses were performed by using StatView for Windows (Ver 5.0.1, SAS Institute, Cary, NC, USA). In ovo EROD data were analyzed by one-and two-factor analysis of variance. All EROD data are reported as means Ϯ standard error of the mean. Deformities were assessed by using the Mann-Whitney U test for analyses with two variables or the Kruskal-Wallis test for analyses with three or more variables. Although deformities were analyzed statistically by using individual severity rankings, deformity data are shown as a deformity index for clarity. Interactions were characterized as synergistic when the effect elicited by the chemical combination was greater than the sum of the individual responses [30] . This interaction was calculated by a one-group chi-square analysis comparing the observed frequencies of deformities to frequencies predicted by an additive interaction (calculated as a sum of the deformity frequency for each treatment; predicted frequency was set to a minimum value of 1 for this analysis because chi-square calculation requires predicted frequency in the denominator of an equation). Chi-square values were summed across the doses for a particular combination of compounds. The null hypothesis for this analysis was that the mixtures tested would elicit response additivity, such that the frequency of observed deformities in embryos dosed with a mixture was not different than the sum of the frequency for each of the individual treatments.
RESULTS
In vitro effects of CB and DBT
Both CB and DBT inhibited in vitro EROD activity in BNFinduced channel catfish microsomes (Fig. 3) . The IC50s for CB and DBT were 27.3 M (95% confidence interval 19.3-38.8) and 12.8 M (95% confidence interval 8.7-18.6), respectively.
In experiments exploring the kinetics of CB-and DBTmediated EROD inhibition, the concentration of the ethoxyresorufin substrate was varied in EROD reactions containing DMSO, 50 M CB, or 20 M DBT (Fig. 4) . Based on preliminary experiments, these concentrations were expected to (Fig. 4A) . Because the V max values for EROD activities of reactions containing CB versus DMSO were different, whereas the K m values were similar, CB was determined to be a noncompetitive EROD inhibitor. The calculated K i for CB was 13.53 M.
A comparison of reactions containing DBT and DMSO yielded V max values of 84.9 (95% confidence interval 73.12-101.2) and 337.5 (95% confidence interval 294.2-395.6) pmol/ min/mg, respectively. The K m values for reactions containing DBT and DMSO were determined to be 0.592 M (95% confidence interval 0.484-0.763) and 0.422 M (95% confidence interval 0.343-0.549), respectively (Fig. 4B) . Because the V max values for reactions containing DBT and DMSO were different, whereas the K m values were similar, DBT also was determined to be a noncompetitive EROD inhibitor. The calculated K i for DBT was 6.7 M.
In ovo effects of CB and DBT
In an experiment testing cotreatment of embryos with a range of CB or DBT concentrations with and without BNF at 1 g/L, BNF significantly induced in ovo EROD about 24-fold over control (p Ͻ 0.0001; Fig. 5 ). Carbazole by itself induced in ovo EROD twofold over control level (p Ͻ 0.0001; Fig. 5A ). Dibenzothiophene by itself lowered in ovo EROD by about 60% compared to controls (p ϭ 0.0001; Fig. 5B ). However, coexposure to BNF with CB and DBT each caused reduced in ovo EROD activities in dose-dependent manners (p Ͻ 0.0001 for each). No significant effect of any treatment was found on embryonic deformities in this experiment (data not shown).
In a second in ovo experiment, embryos were cotreated with a range of BNF concentrations with and without CB at 500 g/L. The BNF treatment induced in ovo EROD about 20-fold over control level (p Ͻ 0.0001; Fig. 6 ). Coexposure to CB lowered in ovo EROD values by greater than 50% of those of embryos dosed with BNF alone (p Ͻ 0.0001). Carbazole by itself caused a threefold EROD induction above control level (p Ͻ 0.0001). The BNF treatment by itself caused deformities (tied p ϭ 0.0010), whereas CB by itself did not cause significant deformities (tied p ϭ 0.9422). Embryos cotreated with BNF and CB had greater deformities than those treated with BNF alone (p ϭ 0.0068).
In the third in ovo experiment, embryos were cotreated with a range of BNF concentrations with and without DBT at 500 g/L. The BNF treatment caused EROD induction (p Ͻ 0.0001; Fig. 7) . The embryos treated with DBT alone had roughly 40% lower EROD value than control embryos, and this effect was nearly significant (p ϭ 0.0567). Embryos coexposed to DBT and BNF had 60 to 70% lower in ovo EROD values than embryos dosed with BNF alone (p Ͻ 0.0001). The BNF treatment by itself caused deformities (tied p ϭ 0.0006); DBT alone did not have a significant impact on deformities (p ϭ 0.1685). Embryos cotreated with BNF and DBT had greater deformities than those treated with BNF alone (tied p ϭ 0.0341).
Chi-square analyses of the observed proportion of deformed embryos in CB-BNF and DBT-BNF cotreatments compared to the proportion predicted by additivity were conducted. The CB-BNF-cotreated embryos did not yield a proportion of deformed embryos different than what would be predicted by an additive model (p ϭ 0.266). However, the proportion of deformed DBT-BNF-cotreated embryos was significantly greater than the proportion predicted by an additive model (p ϭ 0.005), suggesting that the relationship between DBT and BNF is synergistic.
DISCUSSION
In these studies we characterized CB and DBT as noncompetitive inhibitors of CYP1A activity in vitro, by using microsomes from channel catfish livers. Coexposure of embryos to BNF with either CB or DBT reduced in ovo EROD activity; however, it is not known if the in vitro CYP1A inhibition observed in catfish microsomes also occurs in ovo. It is possible that in vivo CB and DBT may not act strictly as CYP1A inhibitors, but may interact with the AHR to reduce AHRmediated CYP1A transcription, causing the decreased in ovo EROD observed.
We recently showed that cotreatment of embryos with PAHtype AHR agonists with a variety of CYP1A inhibitors caused synergistic embryotoxicity [24] . One of the inhibitors used in the previous study was another noncompetitive CYP1A inhibitor, fluoranthene. Fluoranthene increased the embryotoxicity of a complex mixture of PAHs [21] , and was synergistic with BNF [24] . The K i and IC50 values found for CB and DBT in these experiments are similar to those reported for fluoranthene [25, 26] . In rat hepatoma cells, cotreatment with the CYP1A inducer benzo[k]fluoranthene and the inhibitor fluoranthene decreased EROD activity in these cells while not affecting CYP1A protein or message [26] . However, microsomes from fish cotreated with the CYP1A inducer benzo[a]pyrene and fluoranthene had decreased CYP1A protein levels that paralleled the observed decrease in EROD activity, indicating that fluoranthene may reduce AHR-mediated transcription. The effects of CB and DBT cotreatment with BNF on message and protein levels of CYP1A have not been determined.
Because CB and DBT are, like fluoranthene, noncompetitive inhibitors of CYP1A, we hypothesized that the cotreatment of embryos with BNF and CB or DBT would be similarly Effects of CB and DBT on CYP1A activity and deformities Environ. Toxicol. Chem. 24, 2005 2531 synergistic. In concurrence with our hypothesis, BNF-DBT cotreatments were synergistic. Although trends in the data for CB-BNF and DBT-BNF cotreatments were similar, the effect of CB upon BNF-induced deformities could not be statistically distinguished from an additive interaction. One study in zebrafish (Danio rerio) embryos reported that cotreatment of embryos with the partial AHR antagonist and CYP1A inhibitor ␣-naphthoflavone prevented the circulation failure elicited by treatment with BNF [31] . However, in this and previous studies, we have observed that CYP1A inhibitors (including ␣-naphthoflavone) increase the embryotoxicity of BNF and other PAHs in killifish [21, 24] . We do not yet know the mechanism by which CB, DBT, and other CYP1A inhibitors increased embryo deformities in PAH coexposed embryos in these studies.
The overall role of CYP1A activity in the embryotoxicities of AHR agonists is not yet clear and may depend on the type of AHR agonist. Two general classes of AHR agonists are PAHs and planar halogenated aromatic hydrocarbons such as TCDD and polychlorinated biphenyls. Although we have observed increased embryotoxicity in embryos exposed to CYP1A inhibitors with PAH-type AHR agonists [21, 24] , CYP1A inhibitors have been shown to reduce the embryotoxicity of the planar halogenated aromatic hydrocarbons TCDD or 3,3Ј,4,4Ј,5-pentachlorobiphenyl (PCB-126) in medaka (Orizias latipes) [32] , zebrafish [31] , and killifish [24] . One study showed that knockdown of CYP1A expression by morpholino antisense oligonucleotide injection reduced deformities in zebrafish exposed to TCDD [33] . However, a more recent study showed that CYP1A morpholino antisense oligonucleotide injection had no effect on TCDD-induced embryonic deformities [34] . Ongoing studies in our laboratory are examining the roles of the AHR pathway and CYP1A activity in PAH embryotoxicity.
In this study, CB and DBT alone did not elicit deformities. Incardona et al. [35] found that zebrafish exposed to high concentrations (10 mg/L, compared to 0.5 mg/L used in these studies) of DBT exhibited cardiac abnormalities, tail curvature, yolk and pericardial edema, and reduced growth. These symptoms could be mimicked by injection with a morpholino against cardiac troponin T, which prevents the formation of a heart beat, leading the authors to conclude that the cardiac abnormalities observed in the DBT-treated embryos preceded the other abnormalities. We do not know if the mechanism by which this high dose of DBT elicited deformities in zebrafish is similar to the mechanism by which the deformities were elicited by the combined DBT and BNF treatment in this study.
Environmental mixtures of PAHs often contain CB and DBT along with PAH-type AHR agonists [3] ; therefore, the increased embryotoxicity observed in these experiments may be relevant to the embryotoxicity of environmentally occurring PAH mixtures. Although the concentrations of CB and DBT used in these experiments were high, they may be relevant to highly contaminated environments. For example, CB was detected in groundwater at 570 g/L at a site adjacent to a woodtreatment facility in Pensacola, FL, USA [4] and at 150 g/L near a coal gasification plant in Fredericia, Denmark [1] . Many heterocyclic PAHs other than CB and DBT typically occur in PAH mixtures, and to our knowledge, their interactions with AHR agonists and their effects on embryo development have not been determined.
In this study we observed increased embryo deformities elicited by cotreatments of CB and DBT with the model PAHtype AHR agonist, BNF. These data, along with results from previous studies showing that the environmentally occurring compounds fluoranthene and 2-aminoanthracene also inhibit in ovo EROD and cause increased embryo deformities when coexposed with PAH-type AHR agonists [21, 24] , suggest that the interaction between environmentally co-occurring CYP1A inhibitors and AHR agonists may be relevant in environmental PAH mixtures. This interaction may be important to take into account when evaluating the toxicity of these mixtures.
